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Abstract 
Video-enhanced differential interference contrast 
(VDIC) light microscopy in conjunction with fibrinogen 
labelled colloidal gold was employed as a probe to 
follow the mobility of the fibrinogen receptor on 
platelets. Correlative studies by both high voltage and 
scanning electron microscopy confirms localization of 
labels relative to platelet ultrastructural and surface 
characteristics, respectively. Treatment of platelets 
with trifluoperazine prior to and after incubation with 
fibrinogen-gold labels results in a concentration 
dependent inhibition of receptor movement. The results 
obtained from this study suggest that phosphorylation of 
myosin by the Ca++ - calmodulin dependent enzyme, 
myosin-light chain kinase, is important in the fibrinogen 
redistribution that occurs during platelet activation. 
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Introduction 
Loftus and Albrecht ( 17, 18) used fibrinogen 
labelled colloidal gold (Fgn-Au) in conjunction with 
platelet whole mount preparations to directly visualize 
the fibrinogen receptor. These studies have shown that 
platelet shape change is accompanied by fibrinogen 
receptor redistribution and point to a direct correlation 
between fibrinogen receptor redistribution and the 
development of cytoskeletal dependent ultrastructural 
zones; thus suggesting a link between the surface 
receptors and the cytoskeleton. The GPIIb-Ill has been 
identified as the platelet membrane glycoprotein 
complex to which fibrinogen binds (20,23). There have 
been various other studies that also suggest this 
membrane receptor to be associated with the platelet 
cytoskeleton (22,23). 
Actin is the most abundant cytoskeletal protein in 
platelets, accounting for 15-20% of the total platelet 
protein (2). The interaction of actin with myosin 
requires the f.hosphorylation of the 20k myosin light 
chain by Ca + - calmodulin dependent myosin light 
chain kinase (MLCK) (11). Several studies have 
indicated that contractile activity in platelets is a 
function of the state of myosin phosphorylation, and the 
extent of myosin phosphorylation is, in turn, a product 
of the relative activities of myosin kinase and 
phosphatases (1,16). 
Much attention has been focused on the platelet 
cytoskeleton as a determinant of platelet shape change, 
granule secretion, and clot retraction (3,4, 17). The 
present study makes use of correlative VDlC microscopy 
and colloidal gold labeling in conjunction with high 
voltage and scanning electron microscopy to examine 
the involvement of myosin phosphorylation in the 
fibrinogen receptor redistribution that occurs during 
platelet shape change. 
Materials and Methods 
Preparation of colloidal gold 
A stock solution of colloidal gold granules having 
an average diameter of 18 nm was prepared by reducing 
HAuC14 with trisodium citrate (8,9,10,12). A 4% 
solution of HAuC1 4 (0.5 ml) was added to 200 mis of 
deionized distilled water and brought to a boil. A 
freshly prepared solution of 1% trisodium citrate (5 ml) 
was rapidly added to the boiling solution and the 
mixture refluxed for 30 minutes. The formation of the 
monodisperse colloidal particles was indicated by a dark 
blue to red color change. The colloidal solution was 
O.E. Olorundare, S.L. Goodman, and R.M. Albrecht 
cooled, filtered through a microporous filter (Millipore 
Millex - GS 0.22 µm filter unit), and stored at 4°c under 
sterile conditions. 
Preparation of fibrinogen and fibrinogen-gold complex 
Fibrinogen (Fgn) was purified from fresh frozen 
human citrated plasma by precipitation with 25% 
saturated ammonium sulfate followed by DEAE 
cellulose chromatography (19). The final product was 
dissolved in and dialyzed against 0.01 M Tris and 0.14 M 
NaCl buffer pH 7.4. Aliquots of 1 mg/ml were frozen in 
alcohol-dry ice and stored at -7o 0 c. 
Adsorption isotherms were performed to 
determine the minimum amount of fibrinogen necessary 
to stabilize the colloidal gold. The gold solution was 
adjusted to pH 6.5 with 0.2 N K2co 3 as measured by 
gel-filled combination electrode (No. 9115, Orion 
Research Inc., Cambridge, MA). A series of fibrinogen 
solutions of increasing concentration were made up to 1 
ml and added to 5 mis of colloidal gold. After 1 minute 
at room temperature, 1 ml of 10% NaCl solution was 
added to the fibrinogen-gold. Inadequate stabilization 
of the colloid results in flocculation of the gold granules 
indicated by a color change from red to blue. The 
minimum amount of fibrinogen necessary to prevent 
flocculation was• 8 µg/mg of gold solution. 
Ten mis of gold solution (pH 6.5) was added to a 
10% excess of dialyzed fibrinogen (0.005 M NaCl) and 
mixed by gentle inversion. After 5 minutes at room 
temperature, 0.5 ml of freshly prepared and prefiltered 
(Millipore 0.45µm} polyethylene glycol (MW 20,000) was 
added to further stabilize the colloidal gold. The 
fibrinogen labelled gold was concentrated and excess 
fibrinogen removed by centrifugation in polycarbonate 
tubes at 11,000xg for 30 minutes at 4°C. The 
supernatant was discarded, and the concentrated red 
pool was resuspended to 1 ml with sterile filtered 
(Millipore 0.2 µm} protein-free tyrodes buffer 
supplemented with 1 mM Ca++. 
Platelet Preparation 
Platelets were obtained from normal healthy adult 
volunteers by venous puncture. Blood samples (10 ml) 
were collected in polypropylene tubes containing 10 mM 
EGTA and mixed by gentle inversion. Platelet-rich 
plasma was prepared by centrifugation of whole blood at 
180 x g for 10 mins. Platelets were separated from 
plasma proteins by passage through a Sepharose CL-4B 
column (26) having a 40 ml bed-volume. The column 
was equilibrated at room temperature with a calcium-
free tyrodes buffer, pH 7.3 (136 mM NaCl, 2.7 mM KC!, 
0.42 mM NaH 2PO 4, 12 mM NaHCO 3, 2 mM MgClz6H 2O, 
1 g/L dextrose, and 2 g/1 albumm). Platelets were 
collected in the void volume, into polypropylene tubes 
for the experiments. 
Video Microscopy 
Observations of live platelets were performed 
using a video-enhanced differential interference 
contrast (VDIC) light microscope having condenser 
rectification. This is an inverted microscope, designed 
to observe cell attachment. This microscope is built on 
a Nikon diaphot base modifed for both high illumination 
intensity and low light loss, necessary when working at 
the high extinction ratio required for ultimate 
resolution with polarization optics (14). For high 
resolution work using the 1.25 NA l00X objective, the 
final screen magnification of approximately 6000X is 
made available by changing the TV camera projector 
lens. A Dage MTl Newvicon video camera is used for 
its high sensitivity and excellent linearity (0.5%) and is 
modified for manual adjustment of black levels and 
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gain. A Colorado Video processor is used for further 
image enhancement. Micrographs are recorded on 
Kodak plus-x-film either in real time or from video 
tape. Video enhancement increases contrast and 
visibility (15). 
Formvar-coated grids were placed on # 1-1/2 
coverslips and affixed with strips of double-sided tape 
overlying the grid edges. Glass strips cut from 
coverslips were placed on two sides of the grid as shims 
to determine the cell thickness. A single coverslip 
(18X 18 mm, # 1) was then placed on top of the shims and 
sealed in place with melted Valap, a 1:1:1 mixture of 
vasol ine, lanai in, and paraffin. The resultant 
preparation was open at two ends to enable introduction 
and exchange of media by capillary filling. Gold labels 
and/or pharmacologically active agents were added 
while the platelets were being observed. In the present 
study, platelets were treated with the various 
concentrations of trifluoperazine for 5 mins prior to and 
after incubation with Fgn-Au. Platelets were incubated 
with forskolin for 10 mins, followed by the addition of 
Fgn-Au labels. Similarly, glutaraldehyde may be added 
for an initial fixation of the platelets. At the end of 
each experiment, the Valap seal was broken, specimens 
were removed without drying, and processed for 
electron microscopy. 
Electron Microscopy 
Samples were fixed in 0.1 M Hepes buffered 1 % 
glutaraldehyde, 0.2% tannic acid, 0.05% saponin pH 7.2 
for 30 minutes at room temperature. All preparations 
were post fixed in 0.1 M Hepes-buffered 0.05% OsO 4 for 
15 mins, and stained in 1% uranyl acetate (aqueous), for 
15 mins. The specimens were then dehydrated through a 
graded series of alcohol to absolute ethanol, itself dried 
by storage over molecular sieve. Samples were dried by 
the critical point procedure in a critical point dryer 
equipped with an in-line molecular sieve filter and a 
hydrophobic water-excluding filter (24). CO 2 was used 
as the transitional fluid. Samples were evaporatively 
coated with a thin layer of carbon and stored over 
molecular sieve at 0% relative humidity - until 
examined with the AEl EM7 1 MeV electron microscope 
of the Madison HVEM facility. Stereo-pair micrographs 
were taken at tilt angles appropriate for specimen 
thickness and magnification (13). Samples were sputter 
coated with gold-palladium and examined using a JEOL 
JSM 35 scanning electron microscope at 10-20kV 
accelerating voltage. 
Results 
Figure 1 shows a surface activated, fully spread 
platelet that was incubated with Fgn-Au labels. These 
series of VDIC light micrographs depict the progressive 
centralization of the Fgn-Au labels. The final surface 
distribution of labels on light micrograph 1D 
corresponds to the inner filamentous zone as seen by 
HVEM (17,18) and as seen in Fig. 2. Figure 2 shows the 
high voltage electron micrograph (HVEM) of the platelet 
in Figs. lA-D. The structure of the cytoskeleton can be 
seen to be divided into four distinct zones : the 
peripheral web composed of a densely packed meshwork 
of fine filaments, interior to this is the outer 
filamentous zone with its more loosely interwoven array 
of filaments, and finally an inner filamentous zone of 
densely packed overlapping network of filaments 
surrounds the granulomere region. The localization of 
the labels over the inner filamentous zone as seen by 
light microscopy is confirmed by the high voltage 
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Figures lA, B, C and D are a series of VDIC light micrographs of a fully spread platelet treated with Fgn-Au labels 
for 5 minutes. (A) shows the platelet just after addition of Fgn-Au labels. The peripheral web (arrows) is 
unattached to the substratum and can be seen as a dark band due to ruffle induced optical interference. The dark 
regular round spots (g) are platelet granules. The Fgn-Au labels are diffuse at this stage, reflecting the general 
distribution of the,GPilb-lII complexes. Some clusters of labels dense enough to be detected appear on the platelet 
as light gray irregular or oval bands or areas (arrowheads). (B) shows the same platelet 2 minutes after incubation 
with Fgn-Au labels. The more regular black spots on the platelet represent the granules while the irregular bands, 
oval clusters and more irregular spots are indicative of varying densities of Fgn-Au labels (arrowheads). (C) is the 
same platelet taken 3 minutes after addition of Fgn-Au labels. Note the increased density of the irregular dark 
bands and spots due to the large number of Fgn-Au labels clustering on the platelet membrane over the inner 
filamentous zone (arrowheads). (D) shows the platelet 5 minutes after incubation with the labels. The peripheral 
regions are cleared of labels, which are now nearly fully centralized and clearly visible as a dark irregular band 
(arrowheads) surrounding the granulomere region. Picture width= 10.5 µm. 
electron microscopy. Figure 3 is a scanning electron 
micrograph of this same platelet. This shows the 
localization of the Fgn-Au labels on the surface of the 
platelet membrane and on some, but not all, of the 
granules or granule membranes which appear on the 
surface of the platelet during the shape change and 
associated granule release sequence. 
Figures 4A-C are a series of VDIC light 
micrographs showing the redistribution of Fgn-Au labels 
in the spread platelet. Following the centralization of 
labels, the platelet was treated with 50 µM 
trifluoperazine. As shown in Figure 40, treatment with 
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this agent resulted in a decentralization of the Fgn-Au 
labels, and an elongation of the pseudopodia. The high 
voltage electron micrograph of this same platelet is 
depicted in Figure 5. The four distinct ultrastructural 
zones, characteristic of spread platelets are no longer 
evident in this trifl uoperaz ine-treated platelet. The 
Fgn-Au labels have become decentralized and some 
labels have relocated to the elongated pseudopodia and 
over the cytoplasmic processes that have developed. 
The scanning electron micrograph of this platelet, 
demonstrating the surface localization of the labels, is 
shown in Figure 6. We have also observed that 
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Figure 2. HVEM stereo 
pair whole mount of the 
same platelet seen in Figs. 
lA-D. This shows the four 
distinct ultrastructural 
zones: the peripheral web 
(PW), the outer filamentous 
zone (OFZ), the inner 
filamentous zone (!FZ), and 
the granulomere (G). Note 
the location and high 
density of labels which 
appear as small black 
spheres over the inner 
filamentous zone. Labels 
under the peripheral web 
are trapped under the free 
edge (nonsubstrate 
attached) of the platelet 
and do not indicate specific 
binding. Several very 
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(arrows) can be seen. These appear to correlate with the surface presence (see Fig. 3) of granules or membrane 
from degranulated granules which may contain concentrations of the GPIIb/III complex. Certain of these 
externalized granules show minimal or no labelling (stars), also see the same granules in Figure 3. Bar = 1 µm. 
Figure 3. The same platelet as in Figures 1 and 2. 
Scanning electron micrograph clearly demonstrating the 
pattern of surface localization of the Fgn-Au labels 
which appear as tiny light gray spheres. Labels are 
absent from the peripheral areas of the platelet 
membrane i.e. those areas which overlie the peripheral 
web and the outer filamentous zone. Larger light 
spherical to irregular surface bodies (arrows) are 
thought to be granules or granule membranes which 
appear on the platelet surface during degranulation and 
granule exocytosis. Some of these externalized 
membranes show little labelling (stars) while others are 
heavily labelled (see Fig. 2.). This micrograph is rotated 
40° counterclockwise relative to the HVEM micrograph 
(Fig. 2.) Bar = 1 µm. 
pretreatment with 50 µM trifluoperazine prevents the 
initial redistribution of labels in the fully spread 
platelet (results not shown). Platelets were also treated 
with lower concentrations (5, 10, 20 µM) trifluoperazine 
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prior to and after incubation with Fgn-Au labels. These 
concentrations of trifluoperazine did not inhibit, nor 
reverse, redistribution of Fgn-Au labels. A similar 
trend of inhibition of receptor movement observed by 
VDIC light microscopy and confirmed by high voltage 
and scanning electron microscopy was obtained with 
forskolin. While treatment of platelets with 100 µMand 
50 µM forskolin prevented or significantly inhibited 
fibrinogen receptor redistribution, lower concentrations 
(5, 10, 20 µM} did not exert any inhibitory effect on Fgn-
receptor redistribution. 
Discussion 
Studies at the light microscopic level employing 
immunocytochemical techniques have revealed that 
there are temporal changes in the whole cell 
distribution of actin and myosin within the spreading 
platelet (5,21). While actin and myosin initially are 
uniformly distributed within the platelet, they are 
segregated into selective areas as spreading 
progresses. Loftus et al. (17, 18) have also 
demonstrated actin bundles in the pseudopods, while in 
the fully spread platelets, actin filaments are seen in 
the outer filamentous zone and in somewhat higher 
density in the peripheral web and in the inner 
filamentous zone which surrounds the granulomere. 
There are also data to suggest that the platelet 
fibrinogen receptor (GPllb-III complex) is linked to the 
cytoskeletal elements (22,23). This segregation of the 
cytoskeletal proteins during platelet spreading could 
provide the mechanism for force generation and 
discrete inward movement of the receptor. 
In cells, the biochemical equivalence of 
contractile activity is measured in terms of myosin's 
ability to hydrolyze Mg-ATP. In smooth muscles az~ 
vertebrate non-muscle cells such as the platelets, Ca 
regulates the actin-activated Mg-ATPase activity of 
myosin by activating the enzyme myosin light chain 
kinase (MLCK). The effect of Ca++ is mediated through 
the ca++ binding protein calmodulin, which is very 
similar to a number of Ca++ binding proteins in that it 
contains four divalent cation binding sites. Inhibition of 
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Figures 4A, B, C, and D show the VDIC micrographs of a spread platelet. (A) depicts the platelet prior to 
incubation with Fgn-Au labels. The peripheral web is seen here as a dark band (arrows). The dark regular spots in 
the platelet are granules in the granulomere region (g). (B) shows the light micrograph of the same platelet 2 
minutes after the addition of Fgn-Au. Note the diffuse distribution of labels over the entire platelet membrane. 
Areas where labels are concentrated can be seen as medium to dark gray irregular patches, bands and spots 
(arrowheads). Several dark spots beyond the edge of the platelet (X) are granules or granule membranes which have 
come off the platelet during the surface activation and attached to the adjacent substrate. (C) shows the same 
platelet 5 minutes after incubation with Fgn-Au labels. The labels are prominent as a dark irregular band 
surrounding the granulomere (arrowheads). Note also the clearing of labels from the peripheral area of the platelet 
and labelled granule membranes (X) which have come off the platelet. (D) shows the same platelet 4 minutes after 
treatment with 50 µM trifluoperazine. The Fgn-Au labels (arrowheads) have become decentralized and are now 
dispersed individually and in clumps of varying density over the entire platelet membrane. Platelet granules can 
still be found in the granulomere region. Note also that the pseudopodia (enclosed stars) have become elongated, 
prominent and are labelled. The peripheral web (arrows) also appears irregular, consistent with the development of 
small pseudopodia at the platelet margin. This appearance is typical of platelets treated with 50 µ M 
trifluoperazine. Picture width= 10.1 µm. 
this enzyme with calmodulin antagonists prevent 
phosphorylation of myosin and blocks its interaction 
with actin. As shown by our results, inhibition of 
myosin phosphorylation with 50 µM trifluoperazine 
reverses the redistribution of Fgn-Au labels. We have 
also found that pretreatment of platelets with 
trifluoperazine prior to Fgn-Au labelling prevents 
receptor redistribution (data not shown). 
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In our studies, we observed a concentration 
dependent inhibition of receptor redistribution. This 
correlates with previous findings of Fox and Phillips (7) 
in which they showed that preincubation of platelets 
with trifluoperazine caused a concentration dependent 
inhibition of thrombin-induced phosphorylation of 
myosin light chain and incorporation of myosin into the 
platelet cytoskeleton. The maximum inhibition was 
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Figure 5. HVEM stereo 
pair, whole mount of the 
platelet seen in Figs. 4A-D, 
treated with 50 µM 
trifl uoperaz ine for 5 
minutes after incubation 
with Fgn-Au labels for 5 
minutes. Note the 
dispersed distribution of 
labels individually and in 
small patches over the 
entire platelet membrane, 
including the extended 
pseudopodia (arrowheads). 
Bundles of actin filaments 
can be seen extending into 
the large, and many of the 
small, pseudopodia 
(arrows). Note also the 
many cytoplasmic 
processes, and small 
pseudopodia, (a) at the 
• 
• 
margin of the platelet extending from the former position of the peripheral web. Fgn-Au-receptor complexes are 
apparent individually and in small clusters, on the large and small pseudopodia. The four distinct ultrastructural 
zones consistent with cytoskeletal reorganization in the spread platelet are no longer present. Also of interest are 
granules or granule membranes which left the platelet prior to trifluoperazine treatment. Several of these are 
heavily labelled (X) and others (0) are not. Bar= 1 µm. 
Figure 6 shows the scanning electron micrograph of the 
same platelet as in Figs. 4 and 5; treated with 50 µM 
trifluoperazine after incubation with Fgn-Au labels for 
5 minutes. Note the decentralization of the Fgn-Au 
labels (arrowheads) and their surface localization on the 
body of the platelet as well as on pseudopodia and small 
cell processes. Granules and granule membranes can be 
observed on the platelet surface as larger light colored 
spherical bodies. Some have come off the platelet and 
can be seen attached to the surrounding substrate. The 
VDIC micrographs (Figures 4A-D) demonstrate that 
many of these left the platelet as a consequence of 
normal activation prior to trifluoperazine treatment. 
From Fig. 5 (the HVEM of these same granules), some of 
these granules or granule membranes label with 
fibrinogen gold (X) while others (0) do not. Bar = 1 µm. 
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obtained with 50 µM trifluoperazine. The results we 
obtained with forskolin, an adenylate cyclase stimulant 
also lend support to the role of myosin phosphorylation 
and the cytoskeletal proteins in Fgn-receptor 
redistribution. 
Our findings suggest that the modulator protein, 
calmodulin, plays an important role in fibrinogen 
receptor redistribution through a Ca++ -dependent 
phosphorylation of myosin light chain kinase. However, 
these results do not exclude the possibility that 
trifluoperazine could also be affecting enzyme systems 
or proteins other than myosin light chain kinase. 
Sanchez et al (25) have reported that trifluoperazine 
inhibited platelet secretion evoked by activators of 
protein kinase C. However, the concentrations required 
were considerably lower than those which we have 
shown are necessary to block the fibrinogen receptor 
redistribution. The use of VDIC microscopy and 
colloidal gold labelling in conjunction with high voltage 
and scanning electron microscopy is effective in 
following receptor movement on living cells. This is 
also useful in determining the effects of pharmacologic 
agents on receptor distribution and cytoskeletal 
structure. 
It is also of interest to point out that platelet 
granule or granule membranes appear on the surface of 
platelets as a consequence of normal surface activation 
and granule release. Certain of these can be seen by 
VDIC to fall off the platelet during normal activation. 
Subsequent labelling indicates some of these granules to 
label strongly with Fgn-Au whether on or off the 
platelet while others are unlabelled. This would tend to 
support previous findings demonstrating GP!lb-Jll in 
some, but not all, platelet granule membranes (6). 
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Discussion with Reviewers 
D. Handley: The methods of platelet activation using 
formvar grids has been published, so also the Fgn-gold 
labeling method. Do you not think that much of the 
data is duplicative of pre-existing work? 
Authors: The emphasis of the paper is to present the 
techniques relative to colloidal gold labeling. We have 
attempted to show the effective combination of VDIC, 
SEM, and HVEM in conjugation with colloidal gold 
labeling. We specifically wished to demonstrate that 
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the actual movement of the colloidal gold labeled 
receptors, or the inhibition thereof, could be followed in 
living platelets by VDIC and subsequently confirmed and 
related to cytoskeletal structure using SEM and HVEM. 
This approach is unique and has not been previously 
published nor have the findings regarding receptor 
movement relative to inhibitory agents, thus the title 
"Trifluoperazine Inhibition of Fibrinogen Receptor 
Redistribution in Surface Activated Platelets: 
Correlative VDIC, HVEM, and SEM Studies." The 
disposition and labeling of exocytosed platelet granules 
is also a novel finding. 
D. Handley: Do cells not labeled with Fgn-Au display 
the optically dense areas denoted by arrows in Figures 
lA-O? 
Authors: No. The only portions of an unlabeled fully 
spread platelet that show such optical density are the 
granules and cell edges. Figure 7 shows two platelets 
before and after the addition of Fgn-Au. The optical 
density is uniform and low across the unlabeled cells, 
except at cell edges, thin pseudopodia, and over the 
granules (Fig. 7 A). The same cells 15 minutes after 
Fgn-Au addition are shown in Figure 78. The colloidal 
gold labels are clearly seen due to the high optical 
density of the clustered labels. Label is seen over the 
IFZ and granulomere as well as on the pseudopodia of 
the less spread cell. 
D. Handley: How do you know the Fgn-Au labels reflect 
the general distribution of GPllb-111 complexes? 
Authors: Labeling platelets with monoclonal antibody 
directed against GPI!b-111 complex resulted in an 
identical pattern of distribution of the labels. 
Incubation of platelets with soluble fibrinogen followed 
by Au-anti Fgn also showed a similar distribution of 
labels. In addition, pretreatment of platelets with 
fibrinogen prevented binding of Fgn-Au. 
0. Handley: None of the gold labeling in Figure 2 is in 
clusters as large as those shown in Figures lA-O. How 
do you explain that? Could the dense areas in Figures 
lA-O be dense granules? How would you disprove it? 
The TEM picture in Figure 5 showed none of the dense 
labels seen in Figure 40. Can you explain that? 
Reviewer IV: There is no obvious correspondence 
between the large gray bands in the VDIC and the very 
fine particulate gold in EM. How was it determined 
that the Fgn-Au appears as light gray irregular or oval 
bands in Figure 1? 
Authors: HVEM and SEM show Fgn-Au clusters in the 
same places on the platelet as seen by light 
microscopy. The clusters appear larger because the 
18nm colloidal gold labels are an order of magnitude 
smaller than the resolution of the light microscope. 
Thus the labels can not be resolved but are detected due 
to an inflated diffraction image. The dense areas in 
Figures lA-O are not dense granules because they were 
not observed on the platelet prior to the addition of the 
labels. Additionally, the correlative HVEM micrographs 
prove conclusively that dense areas are Fgn-Au, not 
dense granules, which are also clearly identifiable as to 
size and location when viewed by stereo-pair whole 
mount HVEM imaging. The granules which take up 
electron dense stain are often also visible by SEM as 
sub-surface light round or oval areas due to increased 
back scattered electrons and subsequent increased 
secondary electron emission. 
742 
0. Handley: How many times were these experiments 
run? Where in the methods did you state how the 
trifluoperazine and forskolin experiments were done? 
Authors: Experiments with trifluoperazine and forskolin 
have been done at least three times and in each case 
there were controls (i.e., platelets treated with Fgn-Au 
only). The methods section describes how the 
experiments were carried out. 
0. Handley: Treatment with trifluoperazine (TFP) 
caused decentralization of the Fgn-Au labels (Figure 
40) - how much? 
Authors: The extent or degree of decentralization was 
not quantified. However, the localization of labels prior 
to and after the addition of various concentrations of 
TFP to platelets was monitored and as has been 
described, labels can be observed at the peripheral areas 
of the platelet and on newly forming pseudopods that 
were arising from areas which were free of labels prior 
to the addition of TFP. In other words, the labels which 
were previously located only over the central areas of 
the platelet have moved, such that they were 
distributed over the entire cell surface. 
0. Handley: ls the SEM of Figure 6 really different than 
Figure 3? How do you know that? What did you 
measure? On how many cells? 
Authors: Figure 3 depicts a fully spread platelet 
treated with Fgn-Au labels only. The labels have 
clearly moved from the peripheral web and outer 
filamentous zone of the platelet and are present over 
the central area of the platelet. This pattern of 
distribution of labels is characteristic of all the fully 
spread control platelets treated with Fgn-Au. Figure 6 
on the other hand shows the SEM of a spread platelet 
treated with 50 µM TFP following prior incubation of the 
platelet with Fgn-Au labels. Treatment with 50 µM TFP 
caused, as shown and indicated by the arrows, a 
decentralization of the labels resulting in a generalized 
distribution of labels all over the platelet membrane. 
There are also labels on the newly forming pseudopods 
at the platelet margin. Each experiment has been 
performed at least three times with identical results. 
0. Handley: You stated in the abstract that TFP 
"results in a concentration-dependent inhibition of 
receptor movement". What parameters of receptor did 
you measure? How many cells did you measure it on? 
Authors: The parameter measured was whether or not 
Fgn receptors moved to the central area of the platelet 
and hence were cleared from the peripheral areas, i.e., 
absent from the membrane overlying the peripheral web 
and outer filamentous zone. Incubation of platelets 
with 50 µM TFP caused a reversal of Fgn-Au label 
centralization on all (more than 500 fully spread) 
platelets examined in four separate experiments. 
D. Handley: When three concentrations (5, 10, 20 µM) 
did not work and one (50 µM) does, how can you say it is 
concentration dependent? If it is, what is the 1c50 ? 
Why does 50 µM inhibit and not 20 µM? Are these 
concentrations of TFP important? Do they relate to 
other TFP-platelet studies (for example Thromb. Res. 
29: 63-74, 1983)? 
Reviewer IV: Only one concentration of TFP (50 µM) 
resulted in any effect, how then could the authors claim 
that TFP caused a concentration-dependent inhibition of 
receptor movement? The Kd of TFP for calmodulin 
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binding is 1.5 µM and therefore concentrations in this 
range should be effective a7 inhibiting calmodulin dependent processes. At 1 x 10 cells/ml, extrapolation 
of the TFP dose-response curve indicates that 5 µM TFP 
would saturate in vivo calmodulin. Why then did the 
authors fail to obtain any effect of TFP at 
concentrations of TFP below 50 µM, since this appears 
to be a much lower platelet concentration? 
Authors: The effect was concentration dependent in 
that three concentrations were inactive and one was 
active. Subsequently, additional concentrations have 
been tested, 30 and 40 µM, both inhibited Fgn-receptor 
redistribution. Also, treatment of platelets with these 
concentrations of TFP after they have already been 
incubated with Fgn-Au caused decentralization of the 
labels. This data strengthens the case for a 
concentration dependent effect of TFP on Fgn-receptor 
redistribution. We feel it inappropriate to attempt to 
determine the 1c50 or to plot a dose-response curve due 
to the "all or none" nature of the response measured. 
At this point, we see no apparent direct links between 
our results and those presented in Thromb. Res. 29: 63-
74, 1983, except that in both experiments, the effects 
of TFP on different aspects of platelet physiology were 
explored. 
D. Handley: You stated that "inhibition of myosin 
phosphorylation with 50 µM trifluoperazine reverses 
redistribution of Fgn-Au labels". How did you measure 
myosin phosphorylation? 
H.H. Edwards: How have the experiments proven the 
claim that inhibition of myosin phosphorylation reverses 
the redistribution of Fgn-Au labels? 
Authors: We have not studied myosin phosphorylation 
directly but previous work (7) has examined the role of 
phosphorylation in mediating the association of myosin 
with the cytoskeletal structures of human platelets. 
These authors employed similar concentrations of TFP 
as was used in our experiments and observed an 
inhibition of thrombin-induced myosin phosphorylation 
and myosin association with the cytoskeleton, with 
concentrations of TFP greater than 20 µM. This 
suggested to us that myosin phosphorylation might be 
important in Fgn-receptor redistribution; however, 
these results do not exclude the possibility that TFP 
could also be affecting enzyme systems or proteins 
other than myosin light chain kinase. 
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